ASX 200 falls as blue chips plunge

Whilst falls in the sharemarket can be painful, it can also present an opportunity to buy stocks at a discount.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The first day of trading in December saw the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) plunge to its lowest level in seven weeks on Monday, closing down 40.5 points or 0.8% at 5279.5 points after it was weighed down heavily by a basket-full of blue chips.

The miners and banks led the decline with ANZ (ASX: ANZ), Westpac (ASX: WBC), NAB (ASX: NAB) and Commonwealth Bank (ASX: CBA) all falling between 0.2% and 1.3% whilst BHP Billiton (ASX: BHP), Rio Tinto (ASX: RIO) and Fortescue Metals Group (ASX: FMG) dropped between 0.3% and 1.9%.

The falls weren't contained to the mining and bank sectors however. Westfield Group (ASX: WDC), Crown Resorts (ASX: CWN), Suncorp (ASX: SUN), Insurance Australia Group (ASX: IAG) and CSL (ASX: CSL) also declined 1.1% and 2.1%.

The value of share trading swelled to $4.5 billion which, "given the magnitude of the fall, on the first day of the month", suggests that there may be a sizeable sell portfolio, according to Goldman Sachs institutional trader Richard Coppleson. He added that a number of upcoming initial public offerings, including Nine Entertainment and travel insurer Cover-More Group, could also have contributed towards the fall.

Whilst it is expected that the Reserve Bank of Australia (RBA) will keep interest rates on hold at 2.5% on Tuesday, quiet trading conditions are expected for the day.

Foolish takeaway

Having fallen to 5279.5 points, the benchmark index is sitting 3.3% below its high of 5457.3 points which was achieved late in October. Whilst it is never nice to watch the overall value of our portfolios decrease, investors should embrace such a fall as an opportunity to buy underappreciated shares at cheaper valuations that could deliver fantastic gains in the long term.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »